While alterations in the receptor tyrosine kinase-RAS (RTK-RAS) signaling pathway play a fundamental role in colorectal cancer (CRC) biology, their prognostic significance in the setting of FOLFOX chemotherapy-particularly across different age groups and ancestral backgrounds-remains insufficiently characterized. The gene discussed is NTRK1; the disease is colorectal carcinoma.